{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:22:43Z","timestamp":1793064163634,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41375-025-02717-0","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T14:24:09Z","timestamp":1754576649000},"page":"2516-2522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Simultaneous whole-body multi-parametric 2-[18F]FDG-PET\/MRI in smoldering multiple myeloma assessment: diagnostic and prognostic impact"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-9182","authenticated-orcid":false,"given":"Bastien","family":"Jamet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0275-2575","authenticated-orcid":false,"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Necib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Frampas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-9939","authenticated-orcid":false,"given":"Huajun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6289-2229","authenticated-orcid":false,"given":"Chloe","family":"Francois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Blin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-7322","authenticated-orcid":false,"given":"Thomas","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Lilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bodet-Milin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-8746","authenticated-orcid":false,"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Kraeber-Bodere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2717_CR1","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","volume":"125","author":"SV Rajkumar","year":"2015","unstructured":"Rajkumar SV, Landgren O, Mateos MV. Smoldering multiple myeloma. Blood. 2015;125:3069\u201375.","journal-title":"Blood"},{"key":"2717_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348.","journal-title":"Lancet Oncol"},{"key":"2717_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol. 2015;33:657\u201364.","journal-title":"J Clin Oncol"},{"key":"2717_CR4","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1158\/1078-0432.CCR-08-2310","volume":"15","author":"J Hillengass","year":"2009","unstructured":"Hillengass J, Zechmann C, B\u00e4uerle T, Wagner-Gund B, Heiss C, Benner A, et al. Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation. Clin Cancer Res. 2009;15:3118\u201325.","journal-title":"Clin Cancer Res"},{"key":"2717_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/leu.2013.268","volume":"28","author":"M Bhutani","year":"2014","unstructured":"Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, et al. Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia. 2014;28:413\u20136.","journal-title":"Leukemia"},{"key":"2717_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00330-015-3928-4","volume":"26","author":"M Merz","year":"2016","unstructured":"Merz M, Moehler TM, Ritsch J, B\u00e4uerle T, Zechmann CM, Wagner B, et al. Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study. Eur Radio. 2016;26:1404\u201311.","journal-title":"Eur Radio"},{"key":"2717_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/bjh.14038","volume":"174","author":"J Hillengass","year":"2016","unstructured":"Hillengass J, Ritsch J, Merz M, Wagner B, Kunz C, Hielscher T, et al. Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma. Br J Haematol. 2016;174:127\u201335.","journal-title":"Br J Haematol"},{"key":"2717_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/leu.2015.291","volume":"30","author":"E Zamagni","year":"2016","unstructured":"Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bell\u00f2 M, et al. 18F-FDG PET\/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease. Leukemia. 2016;30:417\u201322.","journal-title":"Leukemia"},{"key":"2717_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.87","volume":"5","author":"B Siontis","year":"2015","unstructured":"Siontis B, Kumar S, Dispenzieri A, Drake MT, Lacy MQ, Buadi F, et al. Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy. Blood Cancer J. 2015;5:e364.","journal-title":"Blood Cancer J"},{"key":"2717_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6080-8","volume":"19","author":"L Benaniba","year":"2019","unstructured":"Benaniba L, Tessoulin B, Trudel S, Pellat-Deceunynck C, Amiot M, Minvielle S, et al. The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma. BMC Cancer. 2019;19:855.","journal-title":"BMC Cancer"},{"key":"2717_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, Lecouvet F, Moulopoulos L, Collins DJ, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. 2019;291:5\u201313.","journal-title":"Radiology"},{"key":"2717_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00740-5","volume":"24","author":"B Jamet","year":"2024","unstructured":"Jamet B, Necib H, Carlier T, Frampas E, Bazin J, Desfontis PH, et al. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI\/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET\/MRI imaging approach. Cancer Imaging. 2024;24:93.","journal-title":"Cancer Imaging"},{"key":"2717_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ejrad.2013.04.012","volume":"82","author":"J Dutoit","year":"2013","unstructured":"Dutoit J, Vanderkerken M, Verstraete Koenraad L. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radio. 2013;82:1444\u201352.","journal-title":"Eur J Radio"},{"key":"2717_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00277-017-3078-7","volume":"96","author":"E Terpos","year":"2017","unstructured":"Terpos E, Matsaridis D, Koutoulidis V, Zagouri F, Christoulas D, Fontara S, et al. Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1\/angiopoietin-2 ratio in patients with multiple myeloma. Ann Hematol. 2017;96:1707\u201314.","journal-title":"Ann Hematol"},{"key":"2717_CR15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00330-011-2116-4","volume":"21","author":"C Messiou","year":"2011","unstructured":"Messiou C, Collins DJ, Morgan VA, Desouza NM. Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radio. 2011;21:1713\u20138.","journal-title":"Eur Radio"},{"key":"2717_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magnetic Reson Imaging. 2012;30:1323\u201341.","journal-title":"Magnetic Reson Imaging"},{"key":"2717_CR17","doi-asserted-by":"publisher","first-page":"e210048","DOI":"10.1148\/rycan.2021210048","volume":"3","author":"C Messiou","year":"2021","unstructured":"Messiou C, Porta N, Sharma B, Levine D, Koh DM, Boyd K, et al. Prospective evaluation of whole-body MRI versus FDG PET\/CT for lesion detection in participants with myeloma. Radiol Imaging Cancer. 2021;3:e210048.","journal-title":"Radiol Imaging Cancer"},{"key":"2717_CR18","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","volume":"20","author":"J Hillengass","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV, Durie B, Mateos M-V, Lonialet S, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20:e302\u201312.","journal-title":"Lancet Oncol"},{"key":"2717_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3324\/haematol.10554","volume":"92","author":"E Zamagni","year":"2007","unstructured":"Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007;92:50\u20135.","journal-title":"Haematologica"},{"key":"2717_CR20","doi-asserted-by":"crossref","unstructured":"Paschali A, Panagiotidis E, Triantafyllou T, Palaska V, Tsirou K. Verrouet E al. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy. Eur J Nucl Med Mol Imaging. 2021;48:1487\u201397.","DOI":"10.1007\/s00259-020-05078-1"},{"key":"2717_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2009.25.5356","volume":"28","author":"J Hillengass","year":"2010","unstructured":"Hillengass J, Fechtner K, Weber MA, Bauerle T, Ayyaz S, Heiss C, et al. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol. 2010;28:1606\u201310.","journal-title":"J Clin Oncol"},{"key":"2717_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/leu.2012.309","volume":"27","author":"E Kastritis","year":"2013","unstructured":"Kastritis E, Terpos E, Moulopoulos L, Spyropoulou-Vlachou M, Kanellias N, Eleftherakis-Papaiakovou E, et al. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. Leukemia. 2013;27:947\u201353.","journal-title":"Leukemia"},{"key":"2717_CR23","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/leu.2014.230","volume":"28","author":"E Kastritis","year":"2014","unstructured":"Kastritis E, Moulopoulos LA, Terpos E, Koutoulidis V, Dimopoulos MA. The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma. Leukemia. 2014;28:2402\u20133.","journal-title":"Leukemia"},{"key":"2717_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00004728-199107000-00018","volume":"15","author":"G Brix","year":"1991","unstructured":"Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"2717_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00586-019-06213-9","volume":"29","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen Y, Zhang Y, Zhang E, Yu HJ, Yuan H, et al. Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET\/CT. Eur Spine J. 2020;29:1061\u201370.","journal-title":"Eur Spine J"},{"key":"2717_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00259-020-05049-6","volume":"48","author":"B Jamet","year":"2021","unstructured":"Jamet B, Morvan L, Nanni C, Michaud AV, Bailly C, Chauvie S, et al. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials. Eur J Nucl Med Mol Imaging. 2021;48:1005\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2717_CR27","first-page":"59","volume":"8","author":"A Lakshman","year":"2018","unstructured":"Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, et al. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood. Cancer J. 2018;8:59.","journal-title":"Cancer J"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02717-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:12:29Z","timestamp":1758787949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02717-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02717-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6556935\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}